Anbio Biotechnology (NNNN) Enterprise Value (2023 - 2025)
Historic Enterprise Value for Anbio Biotechnology (NNNN) over the last 3 years, with Q2 2025 value amounting to -$13429.0 billion.
- Anbio Biotechnology's Enterprise Value changed N/A to -$13429.0 billion in Q2 2025 from the same period last year, while for Jun 2025 it was -$13429.0 billion, marking a year-over-year change of. This contributed to the annual value of -$11.8 million for FY2024, which is 2136.89% down from last year.
- Per Anbio Biotechnology's latest filing, its Enterprise Value stood at -$13429.0 billion for Q2 2025.
- Over the past 5 years, Anbio Biotechnology's Enterprise Value peaked at -$9.7 million during Q4 2023, and registered a low of -$13429.0 billion during Q2 2025.
- Moreover, its 3-year median value for Enterprise Value was -$11.8 million (2024), whereas its average is -$4476.3 billion.
- Within the past 5 years, the most significant YoY rise in Anbio Biotechnology's Enterprise Value was 2136.89% (2024), while the steepest drop was 2136.89% (2024).
- Quarter analysis of 3 years shows Anbio Biotechnology's Enterprise Value stood at -$9.7 million in 2023, then dropped by 21.37% to -$11.8 million in 2024, then tumbled by 114171106.58% to -$13429.0 billion in 2025.
- Its Enterprise Value was -$13429.0 billion in Q2 2025, compared to -$11.8 million in Q4 2024 and -$9.7 million in Q4 2023.